The ovarian and cervical cancer cell line selective inhibitors included TG-89 [24] (IC50 = 11.2 ± 7.28 μM; SI >100), a JAK2 inhibitor, and CCT137690 [34] (IC50 = 20.0 ± 7.02 μM; SI >100), an Aurora kinase inhibitor (Supplementary Figure 7 and Table 3). This evidence concerns the gene JAK2 and cervical carcinoma.